Where you live matters: A National Cancer Database study of Medicaid expansion and endometrial cancer outcomes.
Where you live matters: A National Cancer Database study of Medicaid expansion and endometrial cancer outcomes.
复制标题
DOI:
10.1016/j.ygyno.2020.05.018
复制
发表时间:
2020-08
影响因子:
4.7
通讯作者:
Felix AS
中科院分区:
文献类型:
--
作者:
Barrington DA;Sinnott JA;Calo C;Cohn DE;Cosgrove CM;Felix AS
To determine associations between adoption of Medicaid expansion (ME) and changes in insurance status, early stage diagnosis, and cancer survival among women with endometrial carcinoma (EC). The National Cancer Database (NCDB) was queried for patients diagnosed with EC between the age 40–64 from 2004 to 2015. Difference-in-differences analysis quantified the impact of ME on the proportion of new EC diagnoses with insurance (vs. uninsured), the proportion diagnosed with stage I (vs. II-IV), and overall survival. 156,253 patients were included. Among 65,019 women living in ME states, ME is associated with an increase in the percent of EC cases who are insured of 1.4% (95% CI 0.9–2.0%, p < 0.0001), with strongest effects among Hispanic women, women in the lowest income quartile, and women in the second age quartile (age 53–57). There was no overall impact of ME on stage, though an increase of early stage diagnoses by 2.4% (95% CI 0.3–4.5%, p = 0.022) was observed among women age 53–57. There was a trend towards improved overall survival with ME, which was strongest in women age 53–57 (HR = 0.83, 95% CI 0.70–0.99, p = 0.037). Among women with EC, ME positively impacted insurance coverage, an important hurdle in accessing health care. In women aged 53–57, ME was associated with earlier stage at diagnosis and improved survival, suggesting that the magnitude of the improvement in insurance coverage may correlate with important clinical outcomes. Efforts should continue to understand the complexity of barriers to health care access and to develop effective strategies to surmount them.
登录
查看更多内容
DOI:
10.1016/s1470-2045(18)30079-2
发表时间:
2018-03
期刊:
The Lancet. Oncology
影响因子:
--
作者:
de Boer SM;Powell ME;Mileshkin L;Katsaros D;Bessette P;Haie-Meder C;Ottevanger PB;Ledermann JA;Khaw P;Colombo A;Fyles A;Baron MH;Jürgenliemk-Schulz IM;Kitchener HC;Nijman HW;Wilson G;Brooks S;Carinelli S;Provencher D;Hanzen C;Lutgens LCHW;Smit VTHBM;Singh N;Do V;D'Amico R;Nout RA;Feeney A;Verhoeven-Adema KW;Putter H;Creutzberg CL;PORTEC study group
通讯作者:
PORTEC study group
影响因子:
3.7
作者:
Bilimoria KY;Stewart AK;Winchester DP;Ko CY
通讯作者:
Ko CY
影响因子:
158.5
作者:
Matei, Daniela;Filiaci, Virginia;Miller, David S.
通讯作者:
Miller, David S.
影响因子:
6.2
作者:
Maxwell, G. Larry;Tian, Chunqiao;Brewster, Wendy R.
通讯作者:
Brewster, Wendy R.
影响因子:
4.7
作者:
Moss, Haley A.;Havrilesky, Laura J.;Chino, Junzo
通讯作者:
Chino, Junzo